W. L. Gore & Associates has purchased the assets and intellectual property of NMT Medical Inc., including the data related to Closure I, a prospective, multi-center, randomized controlled trial of PFO closure with the Starflex Device (NMT Medical, Inc.) versus best medical therapy for the prevention of recurrent stroke and/or transient ischemic attack (TIA) in patients with cryptogenic stroke/TIA and PFO.
“We made the decision to acquire these assets in the spirit of collaboration and in the interest of advancing scientific and medical understanding,” says Stuart Broyles, PhD, Associate with the Gore Medical Division Stroke Business. The study data were acquired with the rest of the NMT assets, but the transaction did not transfer any liabilities or regulatory obligations of NMT.
Latest from Today's Medical Developments
- Syringe-less injector system for diagnostic imaging obtains fourth FDA clearance
- Hohenstein Medical debuts enhanced medical device testing capabilities
- Arterex unveils unified brand identity
- Dymax demonstrates light-curing material solutions for medical devices
- Able Medical Devices showcases latest sternal closure solutions
- TMTS 2026 explores AI-powered sustainable manufacturing and more
- QT9 QMS platform streamlines quality management, compliance for medical device manufacturers
- Spineology releases patient-specific expandable spinal implant
